On the 28th of September 2016, Global Stem Cells Group successfully hosted its 3rd annual International Stem Cells and Regenerative medicine symposium in Buenos Aires Argentina. This International Stem Cells and Regenerative medicine symposium was dignified by the participation of the most renowned and experienced physicians on stem cell and regenerative medicine from Latin America and Europe.
The symposium was also graced by an online participation of several physicians through online streaming and a speaker lineup which included highly coveted personalities from the areas of scientific research, clinical research and regulatory world. This team of prominent and talented specialists in medical research and international stem cell used the forum to share the recent discoveries and advancements in scientific research and medical science.
During the inauguration of the symposium, Global Stem Cells Group honored Dr. Joseph Purita for his lifetime achievements and contributions to the cellular and regenerative medicine and his guide to the Global Stem Cells Group faculty from its inception. Dr. Purita is a world renowned orthopedic surgeon and the pioneer in laser techniques in orthopedic surgery and the application of stem cells and PRP therapies for orthopedic injuries and diseases.
After the symposium, Stem Cell Training the group’s arm for physician education hosted a full enrollment workshop where several physicians from Latin America and Europe received hands on training on isolation and reintegration of adult stem cells, use of peptides and cellular secretions and orthomolecular interventions. The physicians were trained on global skills and capabilities required for the treatment of patients in the course of their medical practices and for career development.
To learn more about the 3rd Annual International Symposium on Stem Cells and Regenerative Medicine, visit the Global Stem Cells Group website, or email email@example.com, or call 305-560-5337.
About Global Stem Cells Group:
Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions. With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.
Global Stem Cells Group is a publicly traded company operating under the symbol MSSV. https://finance.yahoo.com/quote/mssv/